Acceleron Pharma Inc. (XLRN) — Business segments and KPIs
Revenue by business segment and geography for Acceleron Pharma Inc., with year-over-year trends.
FY 2020
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Royalty | 54.85M | 59.3% |
| License and Service | 25.00M | 27.0% |
| Cost Sharing | 12.67M | 13.7% |